Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma

NCT00448721 is registered in ClinicalTrials.gov with AEterna Zentaris as lead sponsor.

NCT NCT00448721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00448721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
Lead sponsor
AEterna Zentaris
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2007
Completion date
October 31, 2011
Enrollment
24 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma